Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma.
Saved in:
| Title: | Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma. |
|---|---|
| Authors: | Nemunaitis J; Physician Reliance Network, Inc., and Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas 75246, USA., Bohart C, Fong T, Meyer W, Edelman G, Paulson RS, Orr D, Jain V, O'Brien J, Kuhn J, Kowal KJ, Burkeholder S, Bruce J, Ognoskie N, Wynne D, Martineau D, Ando D |
| Source: | Cancer gene therapy [Cancer Gene Ther] 1998 Sep-Oct; Vol. 5 (5), pp. 292-300. |
| Publication Type: | Clinical Trial; Clinical Trial, Phase I; Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print Cited Medium: Print ISSN: 0929-1903 (Print) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 9824048 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nemunaitis+J%22">Nemunaitis J</searchLink>; Physician Reliance Network, Inc., and Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas 75246, USA.<br /><searchLink fieldCode="AU" term="%22Bohart+C%22">Bohart C</searchLink><br /><searchLink fieldCode="AU" term="%22Fong+T%22">Fong T</searchLink><br /><searchLink fieldCode="AU" term="%22Meyer+W%22">Meyer W</searchLink><br /><searchLink fieldCode="AU" term="%22Edelman+G%22">Edelman G</searchLink><br /><searchLink fieldCode="AU" term="%22Paulson+RS%22">Paulson RS</searchLink><br /><searchLink fieldCode="AU" term="%22Orr+D%22">Orr D</searchLink><br /><searchLink fieldCode="AU" term="%22Jain+V%22">Jain V</searchLink><br /><searchLink fieldCode="AU" term="%22O'Brien+J%22">O'Brien J</searchLink><br /><searchLink fieldCode="AU" term="%22Kuhn+J%22">Kuhn J</searchLink><br /><searchLink fieldCode="AU" term="%22Kowal+KJ%22">Kowal KJ</searchLink><br /><searchLink fieldCode="AU" term="%22Burkeholder+S%22">Burkeholder S</searchLink><br /><searchLink fieldCode="AU" term="%22Bruce+J%22">Bruce J</searchLink><br /><searchLink fieldCode="AU" term="%22Ognoskie+N%22">Ognoskie N</searchLink><br /><searchLink fieldCode="AU" term="%22Wynne+D%22">Wynne D</searchLink><br /><searchLink fieldCode="AU" term="%22Martineau+D%22">Martineau D</searchLink><br /><searchLink fieldCode="AU" term="%22Ando+D%22">Ando D</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229432230%22">Cancer gene therapy</searchLink> [Cancer Gene Ther] 1998 Sep-Oct; Vol. 5 (5), pp. 292-300. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Clinical Trial, Phase I; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9432230 <i>Publication Model: </i>Print <i>Cited Medium: </i>Print <i>ISSN: </i>0929-1903 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209291903%22">09291903 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Gene Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=9824048 |
| RecordInfo | BibRecord: BibEntity: Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 292 Titles: – TitleFull: Phase I trial of retroviral vector-mediated interferon (IFN)-gamma gene transfer into autologous tumor cells in patients with metastatic melanoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nemunaitis J – PersonEntity: Name: NameFull: Bohart C – PersonEntity: Name: NameFull: Fong T – PersonEntity: Name: NameFull: Meyer W – PersonEntity: Name: NameFull: Edelman G – PersonEntity: Name: NameFull: Paulson RS – PersonEntity: Name: NameFull: Orr D – PersonEntity: Name: NameFull: Jain V – PersonEntity: Name: NameFull: O'Brien J – PersonEntity: Name: NameFull: Kuhn J – PersonEntity: Name: NameFull: Kowal KJ – PersonEntity: Name: NameFull: Burkeholder S – PersonEntity: Name: NameFull: Bruce J – PersonEntity: Name: NameFull: Ognoskie N – PersonEntity: Name: NameFull: Wynne D – PersonEntity: Name: NameFull: Martineau D – PersonEntity: Name: NameFull: Ando D IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 1998 Sep-Oct Type: published Y: 1998 Identifiers: – Type: issn-print Value: 0929-1903 Numbering: – Type: volume Value: 5 – Type: issue Value: 5 Titles: – TitleFull: Cancer gene therapy Type: main |
| ResultId | 1 |